மருந்துகள் சீராக்கி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்துகள் சீராக்கி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்துகள் சீராக்கி Today - Breaking & Trending Today

Medicines regulator appeals to Treasury for more funding


Medicines regulator appeals to Treasury for more funding
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Medicines regulator appeals to Treasury for more funding
After a cut in Treasury allocation of 8%, authority tells MPs that understaffing affects the speed and efficacy with which it can make regulatory decisions
BL PREMIUM
05 May 2021 - 19:43 Tamar Kahn
The medicines regulator has appealed to the Treasury for a bigger budget, warning that it cannot do its job effectively unless key vacancies are filled.
The SA Health Products Regulatory Authority (Sahpra) shot to public prominence during the coronavirus pandemic as it plays a pivotal role in approving new diagnostics, vaccines and treatments. It is one of the most stringent medicine regulators on the African continent and responsible for overseeing the safety and efficacy of human and animal medicines, medical devices and c ....

Itamar Kahn , National Health , Sa Health Products Regulatory Authority Sahpra , Products Regulatory Authority , Sunday Times , Medicines Regulator , Sa Health Products Regulatory Authority , Boitumelo Semete Makokotlela , தாமரை கான் , தேசிய ஆரோக்கியம் , ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் , ஞாயிற்றுக்கிழமை முறை , மருந்துகள் சீராக்கி , ச ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் ,

Pfizer Withdraws Emergency-Use Application for its COVID-19 Vaccine in India


Pfizer Withdraws Emergency-Use Application for its COVID-19 Vaccine in India
The Central Drugs Standard Control Organisation had earlier declined to approve Pfizer s vaccine without a small local trial on its safety and immunogenicity for Indians.
Syringes seen in front of BioNTech and Pfizer logos. Photo: Reuters/Dado Ruvic/File Photo.
Health05/Feb/2021
New Delhi: Pfizer Inc has withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India that it has developed with Germany’s BioNTech, the company told
Reuters on Friday.
The US company, which was the first drugmaker to apply for emergency use authorisation of its COVID-19 vaccine in India, had a meeting with the Central Drugs Standard Control Organisation on Wednesday and the decision was made after that, the company said. ....

New Delhi , Oxford University Astrazeneca , Indian Council Of Medical Research , Central Drugs Standard Control Organisation On , Central Drugs Standard Control Organisation , Bharat Biotech , Indian Council , New Drugs , Clinical Trial Rules , Bharat Biotech Vaccine , Biontech Pfizer , Corona Virus , Coronavirus Pandemic , Covid 19 Vaccine , Drugs Regulator , Emergency Use Authorisation , Latest Headlines , Latest News , Oxford Astrazeneca Vaccine , Pfizer Vaccine , Top Headlines , Top News , Top Stories , புதியது டெல்ஹி , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன் ,

V G Somani: The DCGI chief, a man known by his actions, 'not of words'


Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
Track the industry of your choice with a daily newsletter specific to that
industry.
Stay on top of your investments. Track stock prices in your portfolio.
NOTE :
This product is a monthly auto renewal product.
Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon. ....

Venugopal Girdharilal Somani , Drug Control Administration Of Gujarat , Drug Control Administration , Visa Credit Card , Standard Digital , Business Standard , Seamless Sign Up , Business Standard Digital , Debit Cards , Net Banking , Payment Wallets , Vg Somani , Drug Controller General Of India , Coronavirus Vaccine , Covid Vaccine , Bharat Biotech , Serum Institute Of India , Drugs Regulator , Drug Regulator , Indian Pharma , வேணுகோபால் கீர்தரிலால் சோமானி , விசா கடன் அட்டை , தரநிலை டிஜிட்டல் , வணிக தரநிலை , தடையற்ற அடையாளம் மேலே , வணிக தரநிலை டிஜிட்டல் ,